Page 42 - NobleCon20-Book-Project

Consumer Staples
Date November 18, 2024 Consumer Staples
52wk High $10.50
52wk Low $5.78 BioHarvest Sciences Inc. CNSX:BHSC $8.50
1140-625 Howe Street
Vancouver, BC V6C 2T6

(USD - in millions) www.bioharvest.com
Market Cap 145.6
Enterprise 152.7
Basic Shares Out. 17.33 COMPANY OVERVIEW
Float 12.57
Institutional Holdings N/A Detailed Analysis:Channelchek.com
Short Interest N/A
Avg. 90-Day Volume 0.01 BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV)
is a leader in Botanical Synthesis, leveraging its patented technology
platform to grow the active ingredients in plants, without the need to
grow the underlying plant. BioHarvest is leveraging its botanical
EPS Data synthesis technology to develop the next generation of science-based
and clinically proven therapeutic solutions within two major business
2022 2023 2024 verticals; as a contract development and production organization
CQ1 N/A N/A N/A (CDMO) on behalf of customers seeking complex molecules, and as a
CQ2 N/A N/A N/A creator of proprietary nutraceutical health and wellness products, which
includes dietary supplements.
CQ3 N/A N/A N/A
CQ4 N/A N/A N/A
CY N/A N/A N/A Source: Channelchek/QuoteMedia

Long-Term EPS Estimate N/A
Price/Book (mrq) 0.39
ROE (ttm) -5955.96
Debt-to-Total Cap. (mrq) 60.78
Fiscal Year End 31-Dec
V
1140-625 How ancouver BC V6C 2T6

Key Executives
CEO: Sobel, Ilan
CFO: Dichter, Bar
COO: Belzer, Ilana
IR: Ryan, David
Noble Capital Markets, Inc.
Source: Capital IQ, Noble Financial estimates, company filings
Noble Senior Analyst 561-994-1191 noblecapitalmarkets.com
Joe Gomes MEMBERS: FINRA, SIPC, MSRB
Following the conference, complete video library of presentations will be
jgomes@noblecapitalmarkets.com available at: channelchek.com | nobleconference.com
(561) 999-2262

Refer to the back of the book for disclosures